PureTech and its Founded Entities collaborate with an extensive network of scientists, clinicians and industry leaders, which has enabled us to consistently gain early access to discoveries well before the rest of the world reads about them and resulting in contributions to over 30 publications in top-tier science journals.

Bill Bradford

Former SVP InterMune; developed pirfenidone for the treatment of IPF

Vincent Cottin

Professor at Université Claude Bernard Lyon; Coordinator of Center for Rare Pulmonary Diseases at Louis Pradel Hospital; Section Editor of the European Respiratory Journal

Kevin Flaherty

Professor at University of Michigan; PhIII trial of nintedanib in pfILD (NEJM)

Toby Maher

Professor & Director of ILD at Keck School of Medicine, USC; PhII trial of pirfenidone in uILDs (Lancet RM)

Paul Noble

Chair, Department of Medicine, Cedars-Sinai; results of two late-stage studies evaluating the effect of pirfenidone in patients w/ IPF (Lancet)

Marlies Wijsenbeek

Chair of Erasmus Medical Center ILD program; PI on study to identify disease progression in patients with newly diagnosed pfILDs

Michael A. Rogawski, Ph.D., M.D.

Professor of neurology and pharmacology at the University of California Davis

Caroline Apovian, MD

Director of the Nutrition and Weight Management Center at Boston Medical Center

Louis J. Aronne, MD, FACP

Sanford I. Weill Professor of Metabolic Research at Weill-Cornell Medical College; Director of the Comprehensive Weight Control Center

Arne Astrup, MD

Head of the Department of Human Nutrition at the University of Copenhagen; Associate Editor of American Journal of Clinical Nutrition

Dennis Ausiello, MD

Director of the Center for Assessment Technology and Continuous Health (CATCH); former Chief of Medicine at Massachusetts General Hospital (MGH)

Alan Breier, PhD

Chief of the Psychotic Disorders Program at Indiana University School of Medicine; former Chief Medical Officer at Eli Lilly

David Elmaleh, PhD

Director of Contrast Media Chemistry at the Massachusetts General Hospital; Associate Professor at Harvard Medical School

Julien Epps, PhD

Associate Professor in Signal Processing with the School of Electrical Engineering and Telecommunications at UNSW Australia

Maurizio Fava, MD

Executive Vice Chair of the Department of Psychiatry; Executive Director of the Massachusetts General Hospital Clinical Trials Network & Institute

B. Brett Finlay, PhD

Howard Hughes Medical Institute Investigator; Professor at the University of British Columbia

Ken Fujioka, MD

Director of the Nutrition and Metabolic Research Center and the Center for Weight Management in La Jolla California at the Scripps Clinic

Adam Gazzaley, MD, PhD

Founding Director of the Neuroscience Imaging Center at the University of California, San Francisco

Allan Geliebter, PhD

Attending Psychologist at St. Luke’s-Roosevelt Hospital

James O. Hill, PhD

Executive Director of the Anschutz Health and Wellness Center; Professor of Pediatrics and Medicine at the University of Colorado School of Medicine, Denver

Kenya Honda, MD, PhD

Associate Professor of Immunology at the Graduate School of Medicine at the University of Tokyo

H. Robert Horvitz, PhD

David H. Koch Professor of Biology at Massachusetts Institute of Technology, Howard Hughes Medical Institute Investigator, and Neurobiologist (Neurology) at Massachusetts General Hospital

Akiko Iwasaki, PhD

Waldemar Von Zedtwitz Professor of Immunobiology and Molecular, Cellular and Developmental Biology and Professor of Molecular Cellular and Developmental Biology, Yale University; Howard Hughes Medical Institute Investigator

Lee M. Kaplan, MD, PhD

Associate Professor at Harvard Medical School; Director of the Metabolism & Nutrition Institute; founding Director of Massachusetts General Hospital Weight Center

Dan Littman, MD, PhD

Howard Hughes Medical Institute Investigator, Professor of Molecular Immunology and Professor of Pathology and Microbiology at the NYU School of Medicine, member of the Board of Director's at Pfizer

Ruslan Medzhitov, PhD

Howard Hughes Medical Institute Investigator; David W. Wallace Professor of Immunobiology at Yale University School of Medicine

Siddhartha Mukherjee, MD, PhD

Assistant Professor of Medicine at Columbia University; Pulitzer Prize-winning author of Emperor of all Maladies

Atul Pande, MD

Former Senior Vice President, Head of Neuroscience, and Senior Advisor, Pharmaceutical R&D at GlaxoSmithKline

Christopher Porter, PhD

Director of the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University in Australia

Alexander Rudensky, PhD

Howard Hughes Medical Institute Investigator, Tri-Institutional Professor at Memorial Sloan-Kettering Cancer Center, the Rockefeller University and Cornell University

Maryanne Senna, MD

Board-Certified Dermatologist at Massachusetts General Hospital and Assistant Professor of Dermatology at Harvard Medical School; Founder and Co-Director of MGH Hair Loss Clinic

Angelo Tremblay, PhD

Professor in the Department of Kinesiology at Laval University, Quebec City